Cited by 81Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and LipoproteinsLiver Disease Diagnosis and Treatment

Effects of Intranasal Insulin on Hepatic Fat Accumulation and Energy Metabolism in Humans

Gancheva, Sofiya, Koliaki, Chrysi, Bierwagen, Alessandra, Nowotny, Peter, Heni, Martin, Fritsche, Andreas, Häring, Hans-Ulrich, Szendroedi, Julia +1 more·2015·Diabetes

Abstract

Studies in rodents suggest that insulin controls hepatic glucose metabolism through brain-liver crosstalk, but human studies using intranasal insulin to mimic central insulin delivery have provided conflicting results. In this randomized controlled crossover trial, we investigated the effects of intranasal insulin on hepatic insulin sensitivity (HIS) and energy metabolism in 10 patients with type 2 diabetes and 10 lean healthy participants (CON). Endogenous glucose production was monitored with [6,6-2H2]glucose, hepatocellular lipids (HCLs), ATP, and inorganic phosphate concentrations with 1H/31P magnetic resonance spectroscopy. Intranasal insulin transiently increased serum insulin levels followed by a gradual lowering of blood glucose in CON only. Fasting HIS index was not affected by intranasal insulin in CON and patients. HCLs decreased by 35% in CON only, whereas absolute hepatic ATP concentration increased by 18% after 3 h. A subgroup of CON received intravenous insulin to mimic the changes in serum insulin and blood glucose levels observed after intranasal insulin. This resulted in a 34% increase in HCLs without altering hepatic ATP concentrations. In conclusion, intranasal insulin does not affect HIS but rapidly improves hepatic energy metabolism in healthy humans, which is independent of peripheral insulinemia. These effects are blunted in patients with type 2 diabetes.

Integrity signals

Registry

Crossref · 10.2337/db14-0892

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nasal insulin did not modulate endogenous glucose production under systemic fasting insulin concentrations in most clinical trials.

    “as nasal insulin did not modulate endogenous glucose production under systemic fasting insulin concentrations in most12,14, but not all, clinical trials11.”
  • IN insulin improves hepatic energy metabolism in healthy humans but not in patients with type 2 diabetes.

    “These outcomes expand findings that IN insulin improves hepatic energy metabolism in healthy humans but not in patients with type 2 diabetes”

    From Intranasal insulin (2021) · cites this paper as [82]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gancheva, S., Koliaki, C., Bierwagen, A., Nowotny, P., Heni, M., Fritsche, A., Häring, H.-U., Szendroedi, J., & Roden, M.
Affiliations
  • Deutsches Diabetes-Zentrum e.V. (DE)
  • German Center for Diabetes Research (DE)
  • Düsseldorf University Hospital (DE)
Corresponding author
Roden, Michael
Venue
Diabetes
Published
2015-01-09
Volume
64
Issue
6
Pages
1966-1975
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2155621221
Cited by
81
References
47
Citations by year
2026: 4 · 2025: 2 · 2024: 6 · 2023: 3 · 2022: 4 · 2021: 10 · 2020: 8 · 2019: 4 · 2018: 9 · 2017: 13 · 2016: 10 · 2015: 8
FWCI
13.42
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
  • Site cant be reached (submittedVersion)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
Funders
  • Helmholtz Alliance Imaging and Curing Environmental Metabolic Diseases
  • Ministry of Science and Research of the State of North Rhine-Westphalia
  • German Federal Ministry of Health
  • German Center for Diabetes Research
  • Schmutzler Stiftung
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
Keywords
intranasal insulin, hepatic insulin sensitivity, hepatic lipid accumulation, hepatic energy metabolism, type 2 diabetes, endogenous glucose production, hepatic ATP, inorganic phosphate, intravenous insulin, insulin resistance
MeSH terms
Administration, Intranasal, Energy Metabolism, Female, Humans, Insulin, Liver, Male, Gas Chromatography-Mass Spectrometry, Middle Aged, Magnetic Resonance Spectroscopy, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review